Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance
New England Journal of Medicine · 23.04.2026 · 394 (16) · 1563-1565
DOI: 10.1056/nejmp2516842 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 23.04.2026. Verfasst von S Sean Tu und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama School of Law, Tuscaloosa. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of Alabama School of Law, Tuscaloosa.
- Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
- Faculty of Law, University of Auckland, Auckland, New Zealand.
ORCID-Profile: S Sean Tu, Jaime King
Zitieren
APA
Tu, S. S., & King, J. (2026). Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance. New England Journal of Medicine, 394(16), 1563-1565. https://doi.org/10.1056/nejmp2516842
Vancouver
Tu SS, King J. Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance. New England Journal of Medicine. 2026;394(16):1563-1565. doi:10.1056/nejmp2516842
BibTeX
@article{Tu2026,
author = {Tu, S Sean and King, Jaime},
title = {Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {16},
pages = {1563--1565},
doi = {10.1056/nejmp2516842}
}
EUVIMED